Mesenchymal stem cells reprogram host macrophages to attenuate obliterative bronchiolitis in murine orthotopic tracheal transplantation
- 1 April 2013
- journal article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 15 (4), 726-734
- https://doi.org/10.1016/j.intimp.2013.03.002
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- In vitro assessment of mesenchymal stem cells immunosuppressive potential in multiple sclerosis patientsImmunology Letters, 2013
- The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report—2011The Journal of Heart and Lung Transplantation, 2011
- Isoleucine or valine deprivation stimulates fat loss via increasing energy expenditure and regulating lipid metabolism in WATAmino Acids, 2011
- Mouse Bone Marrow-Derived Mesenchymal Stromal Cells Turn Activated Macrophages into a Regulatory-Like ProfilePLOS ONE, 2010
- Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cellsClinical and Experimental Immunology, 2009
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 productionNature Medicine, 2008
- Immunomodulatory properties of mesenchymal stromal cellsBlood, 2007
- Mesenchymal stromal cellsCurrent Opinion in Hematology, 2006
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis1Transplantation, 2003